Hyloris Strikes New Deals With AFT And QliniQ Over Novel Valacyclovir Formulation
The Deals Cover Australia, Canada, the Netherlands and New Zealand
The Belgian value-added medicines specialist company struck two commercialization deals over its novel valacyclovir oral suspension that span three continents, marking a further milestone in the product’s development.
